Ingevity Corporation NGVT

73.00 1.21 1.69% as of 25 Sep
Market cap
$2.5B
P/E
47.4×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Revenue
1,160.30 1,177.70 1,167.60 1,048.10

+8 more TTM periods

Cost of Revenue
683.10 711.70 706.10 564.20
Gross Profit
477.20 466.00 461.50 483.90
R&D Expenses
27.20 28.10 28.40 25.20
SG&A Expenses
165.40 170.00 171.20 160.90
Operating Income
137.30 (36.60) (44.00) 207.20
Non-operating Income/Expense
(99.50) (112.90) (98.10) (32.00)
Non-operating Interest Expenses
70.40 74.80 78.30 84.90
EBT
37.80 (149.50) (142.10) 175.20
Income Tax Provision
12.60 6.50 8.20 75.90
Income after Tax
25.20 (156.00) (150.30) 99.30
Net Income Common
54.00 (127.80) (167.10) (65.90)
EPS (Basic)
1.54 (3.50) (4.63) (1.80)
Gross Margin
41.13% 39.57% 39.53% 46.17%
EBIT Margin
11.83% (3.11%) (3.77%) 19.77%
EBT margin
3.26% (12.69%) (12.17%) 16.72%
Net Profit Margin
4.65% (10.85%) (14.31%) (6.29%)
Free Cash Flow Margin
13.35% 20.87% 23.73% 22.86%
EBITDA
237.90 251.40 246.20 494.70
EBIT
137.30 (36.60) (44.00) 207.20
EPS (Diluted, from Cont. Ops)
0.71 (4.29) (4.15) 2.73
EPS (Diluted, from Disc. Ops)
0.00 0.00 0.00 0.00
EPS (Basic, Consolidated)
1.56 (3.48) (4.61) (1.80)
EPS (Basic, from Discontinued Ops)
0.84 0.82 (0.46) (4.56)
EPS (Basic, from Continuous Ops)
0.73 (4.29) (4.15) 2.75
Income from Continuous Operations
25.20 (156.00) (150.30) 99.30
Income from Discontinued Operations
28.80 28.20 (16.80) (165.20)
Consolidated Net Income/Loss
54.00 (127.80) (167.10) (65.90)
EBITDA Margin
20.50% 21.35% 21.09% 47.20%
Operating Cash Flow Margin
18.18% 25.80% 28.37% 28.49%

Fold the line items

In millions of $ except per-share values · columns are period end dates